Upregulating Hif‐1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound

Nonhealing chronic wounds on foot are one of the most dreaded complications of diabetes, and biomedical scaffolds remain an attractive option for repairing or regenerating tissues. Accelerating angiogenesis in the early stage after injury is critical to wound healing process; however, the scaffolds accelerate the angiogenesis in the beginning but with the acceleration of vessel network formation the scaffold network hinders the process. In this study, the water soluble drugs-loaded hydrogel nanofibrous scaffolds are designed for rapidly recruiting angiogenesis relative cells and promoting wound healing. The sustained release profile of desferrioxamine (DFO), which continues for about 72 h, leads to significantly increase of neovascularization. The majority of the scaffold is degraded in 14 d, leaving enough space for cell proliferation and vessel formation. The in vitro results show that the scaffolds upregulate the expression of Hif-1α and vascular endothelial growth factor, and enhance the interaction between fibroblasts and endothelial cells. The in vivo studies show a higher expression of angiogenesis related cytokines. This study demonstrates that the DFO released from hydrogel nanofibrous scaffolds of quick degradation can interfere with the required prolyl-hydroxylases cofactors by acting as Fe(2+) chelator and upregulate the expression of Hif-1α, leading to a significant increase of the neovascularization.

[1]  M. Longaker,et al.  The Role of Hypoxia-Inducible Factor in Wound Healing. , 2014, Advances in wound care.

[2]  L. Deng,et al.  Prolyl Hydroxylase Inhibitors Protect from the Bone Loss in Ovariectomy Rats by Increasing Bone Vascularity , 2014, Cell Biochemistry and Biophysics.

[3]  G. Gurtner,et al.  HIF-1α dysfunction in diabetes , 2010 .

[4]  L. Aiello,et al.  Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States: A Possible Explanation for Impaired Collateral Formation in Cardiac Tissue , 2002, Circulation.

[5]  G. Semenza,et al.  Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice , 2009, Proceedings of the National Academy of Sciences.

[6]  G. Semenza,et al.  Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. , 2010, Cardiovascular research.

[7]  Geoffrey C Gurtner,et al.  Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. , 2003, The American journal of pathology.

[8]  N. Schaper,et al.  The development of global consensus guidelines on the management and prevention of the diabetic foot 2011 , 2012, Diabetes/metabolism research and reviews.

[9]  G. Marti,et al.  Hypoxia and hypoxia‐inducible factor in the burn wound , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[10]  Teresa Pereira,et al.  Stabilization of HIF-1α is critical to improve wound healing in diabetic mice , 2008, Proceedings of the National Academy of Sciences.

[11]  A. Singer,et al.  Ultrafast and fast bioerodible electrospun fiber mats for topical delivery of a hydrophilic peptide. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[12]  W. Saltzman,et al.  An electrospun scaffold integrating nucleic acid delivery for treatment of full-thickness wounds. , 2013, Biomaterials.

[13]  L. Deng,et al.  Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss. , 2012, Bone.

[14]  H. Mansur,et al.  Preparation and characterization of chitosan/poly(vinyl alcohol) chemically crosslinked blends for biomedical applications , 2009 .

[15]  Zhenxing Si,et al.  Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α. , 2013, Diabetes research and clinical practice.

[16]  C. Theoret.  The pathophysiology of wound repair. , 2005, The Veterinary clinics of North America. Equine practice.

[17]  C. Metz.  Fibrocytes: a unique cell population implicated in wound healing , 2003, Cellular and Molecular Life Sciences CMLS.

[18]  Jian Gong,et al.  Fabrication and characterization of poly (vinyl alcohol)/chitosan blend nanofibers produced by electrospinning method , 2007 .

[19]  P. Opanasopit,et al.  Electrospun chitosan/polyvinyl alcohol nanofibre mats for wound healing , 2014, International wound journal.

[20]  R. Bucala,et al.  Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  S. Tangl,et al.  Dimethyloxalylglycine lyophilized onto bone substitutes increase vessel area in rat calvarial defects. , 2015, Clinical oral implants research.

[22]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[23]  A. Abbas,et al.  Unconfined compression properties of a porous poly(vinyl alcohol)-chitosan-based hydrogel after hydration. , 2009, Acta biomaterialia.

[24]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[25]  N. Andrews.  Disorders of iron metabolism. , 1999, The New England journal of medicine.

[26]  Z. Bing,et al.  Dimethyloxalylglycine Prevents Bone Loss in Ovariectomized C57BL/6J Mice through Enhanced Angiogenesis and Osteogenesis , 2014, PloS one.

[27]  A. Boulton,et al.  The global burden of diabetic foot disease , 2005, The Lancet.

[28]  L. Deng,et al.  New bone formation in a true bone ceramic scaffold loaded with desferrioxamine in the treatment of segmental bone defect: a preliminary study , 2012, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[29]  M. Franz,et al.  Impaired Laparotomy Wound Healing in Obese Rats , 2011, Obesity surgery.

[30]  G. Gurtner,et al.  The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues , 2009, Proceedings of the National Academy of Sciences.

[31]  M. Amin,et al.  Accelerated wound healing and anti-inflammatory effects of physically cross linked polyvinyl alcohol–chitosan hydrogel containing honey bee venom in diabetic rats , 2014, Archives of pharmacal research.

[32]  Amitava Das,et al.  A modified collagen gel enhances healing outcome in a preclinical swine model of excisional wounds , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[33]  Bin Li,et al.  A highly flexible paclitaxel-loaded poly(ε-caprolactone) electrospun fibrous-membrane-covered stent for benign cardia stricture. , 2013, Acta biomaterialia.

[34]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[35]  M. Murali,et al.  PVA-chitosan composite hydrogel versus alginate beads as a potential mesenchymal stem cell carrier for the treatment of focal cartilage defects , 2015, Knee Surgery, Sports Traumatology, Arthroscopy.

[36]  G. Gurtner,et al.  Quantitative and reproducible murine model of excisional wound healing , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[37]  L. Dahners,et al.  An evaluation of carrier agents for desferoxamine, an up-regulator of vascular endothelial growth factor , 2013, Journal of biomaterials applications.